It is a semaglutide like Ozempic and Wegovy, but it does not need to be injected
Reviewed by: WPG Research Team, Health & Wellness Editor Last Updated: February 7, 2026 | Sources: NEJM, Nature Medicine, Eli Lilly, FDA.gov, ClinicalTrials.gov The Bottom Line on Retatrutide Retatrutide shows among the highest weight loss results reported in any Phase 3 obesity drug trial to date (~28.7% body weight at 68 weeks)
CPT1 catalyzes the transfer of the acyl group from Coenzyme A to a molecule of L-carnitine, creating a newly formed complex called acylcarnitine
Some people report mild digestive discomfort, particularly when starting at higher doses
Consequently, semaglutide users may represent a subgroup with greater metabolic burden, introducing selection pressures not fully mitigated by our design